Growth inhibition of androgen-insensitive human prostate carcinoma cells by a 19-norsteroid derivative agent, mifepristone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Growth inhibition of androgen-insensitive human prostate carcinoma cells by a 19-norsteroid derivative agent, mifepristone

Published:1995-04 Issue:4 Volume:26 Page:194-204
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Lin Ming-Fong,Kawachi Mark H.,Lin Fen-Fen,Stallcup Michael R.,Grunberg Steven M.

Publisher

Wiley

Subject

Urology,Oncology

Reference46 articles.

1. Carcinoma of the Prostate

2. , : Cancer of the prostate. In (ed): “Clinical Oncology—A Multidisciplinary Approach.” New York: American Cancer Society, 1983, pp 210–213.

3. Hormonal Therapy of Prostatic Cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis;Cancers;2021-04-01

3. Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma;Scientific Reports;2018-04-03

4. Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy;Molecular and Cellular Endocrinology;2018-02

5. Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer;Anticancer Research;2017-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP